Abstract
A seven-valent pneumococcal polysaccharide-CRM197 carrier protein conjugate vaccine (PNC7V; Prevenar, Wyeth, Paris) targets the serotypes (belonging to serogroups 14, 6, 19, 18, 23, 9, and 4) most often responsible for invasive pneumococcal disease (IPD) among children. A randomized, controlled, double-masked study among 37,868 children in northern California (Northern California Kaiser Permanente, USA) provided a per protocol vaccine efficacy value of 97.7% against invasive pediatric IPD due to the vaccine serotypes. The PNC7V vaccine was registered by the European Agency for the Evaluation of Medicinal Products (EMEA) in October 2000; a favorable "Community Marketing Decision" under the Centralized Procedure was granted in February 2001. PNC7V was recommended for most infants by the Conseil Supérieur d'Hygiène Publique de France in March 2002, on the advice of the Comité Technique des Vaccinations, as S. pneumoniae in children less than 2 years of age is the primary cause of bacterial meningitis and of mortality associated with community-acquired bacterial infections. The theoretical coverage of the vaccine towards pneumococcal invasive disease in France is about 80%, which represents one of the best serotype coverage estimat...Continue Reading
References
Feb 19, 1999·International Journal of Epidemiology·I VenetzK Mühlemann
Sep 24, 1999·The Pediatric Infectious Disease Journal·H R ShinefieldJ Hansen
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Apr 5, 2000·The Pediatric Infectious Disease Journal·S BlackK Edwards
Dec 20, 2000·The Journal of Infectious Diseases·K SleemanUNKNOWN Oxford Pneumococcal Surveillance Group
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
May 15, 2002·The Pediatric Infectious Disease Journal·Henry ShinefieldEdwin Lewis
May 23, 2002·Archives of Disease in Childhood·E D G McIntosh, R Booy
Jun 18, 2002·Scandinavian Journal of Infectious Diseases·Moe H KyawHarry Campbell
Dec 21, 2002·European Journal of Pediatrics·Mark A FletcherBernard Fritzell
Dec 21, 2002·European Journal of Pediatrics·Willam P Hausdorff
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Jul 3, 2003·Pediatrics·Sharon NachmanUNKNOWN Pediatric AIDS Clinical Trials Group Study 292 Team
Citations
Jul 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Wei KongRoy Curtiss
Jul 8, 2005·Journal of Clinical Microbiology·Damien M O'halloran, Mary T Cafferkey
Jul 17, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A DesrumauxI Pin
Oct 8, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·M BouskraouiE Bingen
Apr 28, 2009·Médecine et maladies infectieuses·E Varon
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Marilla G LuceroHelena Makela
Aug 9, 2013·Clinical and Vaccine Immunology : CVI·Calvin C DanielsDavid E Briles
Jul 16, 2010·Acta Paediatrica·C AlexandreA Martinot
Nov 4, 2015·Scientific Data·Nicholas J CroucherWilliam P Hanage
Jan 8, 2010·Clinical and Vaccine Immunology : CVI·Huoying ShiRoy Curtiss
Dec 21, 2019·Microbiology Spectrum·D E BrilesM J Crain